Vibrio vulnificus strains isolated from geographically diverse marine sources were compared with clinical isolates for phenotype and in vitro and in vivo production of virulence factors. There were no differences between environmental and clinical strains on the basis of biochemical characteristics or antimicrobial susceptibility patterns. Cytolysin and cytotoxin titers produced by environmental strains were generally comparable to those of clinical strains. Of 29 environmental isolates tested, 25 were pathogenic for mice. These data show that environmental V. vulnificus strains are phenotypically indistinguishable from clinical isolates and that approximately 90% of the environmental strains tested produced in vitro virulence factors and in vivo pathogenicity for mice comparable to those produced by clinical V. vulnificus isolates.
The marine bacterium Vibrio vulnificus was first described by Reichelt et al. (14) as Beneckea vulnifica. Subsequent taxonomic revisions have placed this organism in the genus Vibrio as V. vulnificus (2, 8) . Early case reports of clinical infections referred to this organism as the lactose-positive, LAC+, or L+ vibrio (9, 11) . Two major clinical presentations are associated with V. vulnificus infections: wound infections, which frequently require extensive debridement, and primary septicemia, which has a mortality rate of near 50%. Wound infections are generally acquired from exposure to seawater or marine animals, while primary V. vulnificus septicemias are most commonly associated with the consumption of raw oysters (3) . Several factors have been described which may be associated with the virulence of V. vulnificus strains. These include the resistance of V. vulnificus strains to the bactericidal activity of human serum (6) , the role of increased iron availability (22) , and the production of cytolytic and cytotoxic extracellular factors (12) . The role of these virulence factors in the in vivo pathogenesis of V. vulnificus infections largely remains to be determined.
Vibrio vulnificus has been isolated from numerous marine environments (10, 13, 16) ; the highest densities are generally found in areas of high temperature (>20°C) and low to moderate salinity (5 to 20 %o).
The majority of environmental isolates of V. cholerae and V. parahaemolyticus differ from strains of these species isolated from individuals with clinical infections. Environmental isolates of V. cholerae are predominantly nontoxigenic, non-O1 serovars, whereas the majority of clinical strains are toxigenic, 01 V. cholerae (4) . Similarly, most V. parahaemolyticus strains isolated from marine sources fail to produce the Kanagawa hemolysin, while the majority of strains isolated from cases of gasteroenteritis produce the Kanagawa hemolysin (15) . It was our goal to determine whether differences between environmental and clinical strains of V. vulnificus could be identified. Phenotypic characteristics, the ability to produce certain virulence factors, and animal pathogenicity were examined. (18, 19) . Antimicrobial susceptibility testing was done by the standardized disk diffusion method (1) . The cytolytic activity of heart infusion broth (Difco Laboratories, Detroit, Mich.) cultures against sheep erythrocytes was assayed as described previously (17) . Cytotoxic activity was determined by using McCoy cells and a modification of the procedure for the detection of Clostridium difficile cytotoxin (7) . McCoy cell monolayers in a 96-well microtiter tray were inoculated with 1:10, 1:20, 1:100, and 1:200 dilutions of heart infusion broth culture supernatants. Cytotoxicity was determined by microscopic examination ofthe cell monolayer after 18 to 24 h of incubation at 35°C. The highest dilution producing cytopathic effects,' identified as rounding of the McCoy cells, was designated the cytotoxin titer. Animal pathogenicity was determined by using Institute of Cancer Research (ICR) strain male mice, weighing 30 g each. V. vulnificus strains were grown for 4 h at room temperature in tryptic soy broth without glucose (Difco). These conditions were chosen since previous studies showed that they are the conditions under which cytolysin production is minimal (17) . Cell densities were adjuste'd by diluting to a turbidity comparable to a McFarland 0.5 nephelometer standard. Three mice were injected intraperitoneally with about 108 cells (0.5 ml) for each V. vulnificus strain tested. This inoculum concentration was also used in previous virulence studies in mice (5) . Our preliminary studies showed that this inoculum concentration produced no nonspecific toxicity and that there was no difference between washed and unwashed cells when test strains were grown under the conditions described above. Mice were examined about 1 h after inoculation to ensure that no deaths resulted from inoculum toxicity or trauma as a result of inoculation. Bacterial cell densities in the inocula were checked by plate counts. Sterile broth controls were included in each set of experiments. Mice were examined after 24 and 48 h', and the number of survivors was recorded.
RESULTS AND DISCUSSION Biochemical characteristics. The phenotypic characteristics of 31 environmental V. vulnificus isolates are shown in (.1:20) . Of 29 marine strains tested, 3 (10%) produced cytolysin (hemolysin) titers below those produced by clinical isolates of V. vulnificus (1:40). Of 27 marine strains, 1 produced a cytotoxin titer of <1:20, which was less than the lowest cytolysin titer (1:20) produced by the 13 clinical strains tested.
Results of the in vitro and in vivo virulence assays and the source of individual marine strains are shown in Table 5 . All clinical V. vulnificus strains tested killed at least two mice in each set of three inoculated. Of 29 marine V. vulnificus strains, 21 killed at least two of three mice in each set, while 4 marine strains killed one of three mice. Four environmental V. vulnificus strains failed to kill mice. All V. vulnificus strains which killed fewer than two mice per set were retested and confirmed as low-virulence strains. Three of the four environmental V. vulnificus isolates which were avirulent (failed to kill mice) also produced low cytolysin (hemolysin) titers in vitro (<1:40). The in vitro assay for hemolytic activity of culture supernatants appears to be a reliable, simple, and inexpensive method for screening V. vulnificus strains for further virulence studies.
In conclusion, there were no notable differences in phenotypic characteristics between clinical and environmental isolates of V. vulnificus when either biochemical characteristics or antimicrobial susceptibilities were compared. No distinct biogroups can be identified on the basis of the characteristics presented in Tables 1 and 2 . Production of virulence factors both in vitro (cytolysin and cytotoxin) and in vivo (mouse pathogenicity) was similar among clinical and marine V. vulnificus strains. Of the environmental V. vulnificus isolates tested, 90 and 96% produced cytolysin and cytotoxin titers, respectively, which were comparable to results for clinical isolates. Of the marine strains, 86% were pathogenic for mice. Several marine V. vulnificus strains (4 of 29) which could be regarded as avirulent were identified. These strains produced low titers of cytolysin and cytotoxin in vitro or failed to kill mice when about 108 bacteria were injected intraperitoneally, or both. However, approximately 90% of the V. vulnificus strains isolated from geographically diverse marine sources were comparable in virulence to clinical strains tested. These data support the conclusion that exposure to V. vulnificus either by the consumption of raw shellfish, particularly oysters, or contact with brackish or marine waters represents a potential public health hazard. This hazard is apparently most significant during summer months in areas of low to moderate salinity (5 to 20%6) with water temperatures greater than 20°C, when numbers of V. vulnificus strains would be expected to be maximal (10, 16 
